AL
GSK icon

Aspiriant LLC’s GSK GSK Stock Holding History

Aspiriant LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
10,267
+1,773
+21% +$93.8K 0.01% 233
2026
Q1 		$469K Buy
8,494
+309
+4% +$16.7K 0.01% 228
2025
Q4 		$401K Buy
8,185
+185
+2% +$8.63K 0.01% 240
2025
Q3 		$345K Sell
8,000
-119
-1% -$4.65K 0.01% 234
2025
Q2 		$312K Sell
8,119
-122
-1% -$4.66K 0.01% 246
2025
Q1 		$319K Buy
+8,241
New +$302K 0.01% 230
2020
Q4 		– Sell
-4,960
Closed -$233K – 213
2020
Q3 		$233K Buy
+4,960
New +$249K 0.02% 198
2018
Q2 		– Sell
-5,040
Closed -$246K – 253
2018
Q1 		$246K Buy
+5,040
New +$235K 0.02% 212

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aspiriant LLC's GSK Position: Q2 2026 in Review

Aspiriant LLC increased its GSK (GSK) stake by 21% in Q2 2026, buying an estimated $93.8K and bringing the position to 10,267 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #233.

Aspiriant LLC first reported a position in GSK in Q1 2018 and has held it in 8 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Aspiriant LLC held 10,267 shares of GSK worth $538K as of Q2 2026.
  • Aspiriant LLC bought 1,773 GSK shares in Q2 2026, an estimated $93.8K.
  • GSK made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #233 holding.
  • Aspiriant LLC first reported a position in GSK in Q1 2018 and has held it in 8 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.